BioArctic AB
556601-2679ActiveDeveloping innovative drugs for neurodegenerative CNS disorders through advanced research.
Yleiskatsaus
- 100–199
- Työntekijät
- 100–500milj SEK
- Liikevaihto
- 2000
- Perustettu
Avainpäättäjät
Petter Weréen
Senior Director Business Development
Oskar Bosson
VP, Head of IR & Communication
Charlotte af Klercker
Sr Director Sustainability & Communications
Lars Lannfelt
Board member
+18 lisää yhteystietoja Funnelfeedrissä
Kuvaus
BioArctic is a Swedish research-oriented biopharma company dedicated to revolutionizing treatments for neurodegenerative disorders. The organization focuses intensely on developing disease-modifying drugs for conditions such as Alzheimer’s disease, Parkinson’s disease, and ALS. They leverage 20 year...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE556601267901
Päättäjät
22 yhteystietoa FunnelfeedrissäPetter Weréen
Senior Director Business Development
Oskar Bosson
VP, Head of IR & Communication
Charlotte af Klercker
Sr Director Sustainability & Communications
Lars Lannfelt
Board member
Anna-Lena Engwall
Board member
Mikael Moge
VP, Head of CMC
Cecilia Edström
Board member
Lotta Ljungqvist
Board member
Eugen Steiner
Chairman of the board
Anna-Kaija Grönblad
CCO, Head of Commercial Operations
Biljana Rizoska
VP Head of Research
Anders Martin-Löf
CFO
Johanna Fälting
Chief R&D Officer, Head of Research & Development
Mikael Smedeby
Board member
Pär Gellerfors
Board member
Rebecca Kastell
VP, Head of HR
Christer Möller
Chief Scientific Officer
Gunilla Osswald
CEO & President
Gabrielle Åhlberg Hillert
CMO, Head of Clinical & Regulatory Affairs
Emilie Ankarcrona Smith
General Counsel, Head of Legal & IP
Anna Lena Engwall
Member of the Audit Committee
Muut yhteyshenkilöt
Per-Ola Freskgård
Distinguished Scientist
Samankaltaiset yritykset
20 samankaltaista yritystä Funnelfeedrissä
BioArctic Finland Oy
Swedish biopharma developing treatments for neurodegenerative diseases.
BIOARCTIC NORWAY AS
6 työntekijätDeveloping disease-modifying treatments for neurodegenerative disorders.
PTC Therapeutics Sweden AB
Developing transformative treatments for rare diseases globally for patients.
Alnylam Sweden AB
5–9 työntekijätLeading RNAi therapeutics company developing gene-silencing medicines.
Grespo AB
0 työntekijätYoung biomedical company developing CNS treatments based on 2-oxoglutarate research.
Selaa lisää
Kysymyksiä yrityksestä BioArctic AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo